Mosaic ImmunoEngineering (CPMV) Operating Margin (2010 - 2011)
Mosaic ImmunoEngineering (CPMV) posted quarterly Operating Margin of 1641.83% for Q4 2011, up 75191.0% year-over-year from N/an in Q4 2010, and down 174.37% quarter-over-quarter from 598.4% in Q3 2011.
Mosaic ImmunoEngineering (CPMV) Operating Margin (2010 - 2011) Analysis & Trends
Mosaic ImmunoEngineering's Operating Margin history runs 2 years deep, the most recent figure standing at 1641.83% for Q4 2011.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Operating Margin (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 139.25 Bn | 131.40 Bn | 2.84 Bn | 37.40% |
| 2 | Regeneron Pharmaceuticals | 86.04 Bn | 78.05 Bn | 3.93 Bn | 30.15% |
| 3 | Argenx Se | 65.43 Bn | 60.25 Bn | 1.37 Bn | 32.54% |
| 4 | Moderna | 58.26 Bn | 53.13 Bn | 52.00 Mn | -562.07% |
| 5 | BeOne Medicines | 42.10 Bn | 37.00 Bn | 1.53 Bn | 19.06% |
| 6 | Alnylam Pharmaceuticals | 31.61 Bn | 28.31 Bn | 992.69 Mn | 17.93% |
| 7 | BioNTech SE | 28.03 Bn | 9.63 Bn | 668.28 Mn | -35.57% |
| 8 | Insmed | 27.49 Bn | 26.33 Bn | 358.27 Mn | -0.36% |
| 9 | Royalty Pharma | 27.33 Bn | 26.49 Bn | - | 19.75% |
| 10 | Mosaic ImmunoEngineering | 3.68 Mn | 3.68 Mn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Nov 30, 2011 | -1,641.83% |
| Aug 31, 2011 | -598.40% |
| Nov 30, 2010 | -2,393.73% |
| Aug 31, 2010 | -1,684.65% |